[go: up one dir, main page]

CN115215816B - A kind of synthesis method of lactam compounds - Google Patents

A kind of synthesis method of lactam compounds Download PDF

Info

Publication number
CN115215816B
CN115215816B CN202210417647.9A CN202210417647A CN115215816B CN 115215816 B CN115215816 B CN 115215816B CN 202210417647 A CN202210417647 A CN 202210417647A CN 115215816 B CN115215816 B CN 115215816B
Authority
CN
China
Prior art keywords
reaction
add
water
completed
nitrophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210417647.9A
Other languages
Chinese (zh)
Other versions
CN115215816A (en
Inventor
褚长虎
马天华
刘朝阳
杨金金
施冬克
贾强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seasons Biotechnology Taizhou Co Ltd
Original Assignee
Seasons Biotechnology Taizhou Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seasons Biotechnology Taizhou Co Ltd filed Critical Seasons Biotechnology Taizhou Co Ltd
Publication of CN115215816A publication Critical patent/CN115215816A/en
Application granted granted Critical
Publication of CN115215816B publication Critical patent/CN115215816B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention provides a synthesis method of lactam compounds, which uses sodium chlorite as an oxidant to oxidize cyclic amine compounds into lactam compounds under the catalysis of carbon dioxide. The synthesis method provided by the invention has the characteristics of green and high efficiency, mild reaction conditions, high yield, high purity, convenient post-treatment and easy industrial application.

Description

一种内酰胺类化合物的合成方法A kind of synthesis method of lactam compounds

技术领域Technical field

本发明属于化学合成技术领域,具体涉及将环状胺类化合物氧化为内酰胺类化合物的合成方法。The invention belongs to the technical field of chemical synthesis, and specifically relates to a synthesis method for oxidizing cyclic amine compounds into lactam compounds.

背景技术Background technique

内酰胺类化合物是许多药物的关键中间体,在药物合成领域具有广泛的应用。如临床常用的抗血栓药物利伐沙班和阿哌沙班,其分子结构中均存在内酰胺类的结构。内酰胺类化合物可作为中间体引入到目标药物结构中,其合成方法可以通过直接氧化环状胺类化合物得到,从而达到简化原料药合成工艺的目的。Lactam compounds are key intermediates for many drugs and have wide applications in the field of drug synthesis. For example, the commonly used clinical antithrombotic drugs rivaroxaban and apixaban have lactam structures in their molecular structures. Lactam compounds can be introduced into the target drug structure as intermediates, and their synthesis method can be obtained by directly oxidizing cyclic amine compounds, thereby simplifying the synthesis process of raw materials.

常用的通过氧化环状胺类化合物得到内酰胺的方法有过渡金属催化氧化法和非金属催化氧化法,过渡金属催化氧化法使用了过渡重金属作为催化剂,造成工艺成本高,产品存在残留金属元素超标的风险,不适合产业化应用;非金属催化氧化法使用非金属氧化剂对环状胺进行氧化,较之过渡金属催化氧化法,避免了过渡重金属的使用,工艺成本相对降低,更适合产业化应用。Commonly used methods to obtain lactams by oxidizing cyclic amine compounds include transition metal catalytic oxidation and non-metal catalytic oxidation. The transition metal catalytic oxidation method uses transition heavy metals as catalysts, resulting in high process costs and excessive residual metal elements in the product. risks and is not suitable for industrial applications; the non-metal catalytic oxidation method uses non-metal oxidants to oxidize cyclic amines. Compared with the transition metal catalytic oxidation method, it avoids the use of transition heavy metals, and the process cost is relatively reduced, making it more suitable for industrial applications. .

Femando Sartillo-Piscil等于2018年发表在J.Org.Chem.(2018,83,15333-15346)的文献中描述了使用非金属催化氧化法将吗啉类化合物氧化得到吗啉酮类化合物的方法,该方法以亚氯酸钠(3当量)和次氯酸钠(0.7当量)作为氧化剂,TEMPO(四甲基哌啶氮氧化物)(0.1当量)作为催化剂,外加pH值调节剂NaH2PO4(3当量)作为氧化体系,实现了非金属催化氧化。然而,该反应缺点同样明显,整个反应体系中加入了太多的盐类,进行产业化时,会产生大量的固废或废液;此外,TEMPO价格较高,有毒,可经皮肤吸收,有刺激性,对实验人员有一定的使用风险,且结构在酸碱条件下不稳定,易分解,造成产物中杂质多,难于回收利用,容易对环境造成污染。因此,该方法成本较高,且不符合现阶段的绿色环保的化工要求。Femando Sartillo-Piscil et al. published in J.Org.Chem. (2018, 83, 15333-15346) in 2018 described a method of using a non-metal catalytic oxidation method to oxidize morpholine compounds to obtain morpholinone compounds. This method uses sodium chlorite (3 equivalents) and sodium hypochlorite (0.7 equivalents) as oxidants, TEMPO (tetramethylpiperidine nitrogen oxide) (0.1 equivalents) as a catalyst, and a pH adjuster NaH 2 PO 4 (3 equivalents). ) as an oxidation system, realizing non-metal catalytic oxidation. However, the disadvantages of this reaction are also obvious. Too many salts are added to the entire reaction system, which will produce a large amount of solid waste or waste liquid during industrialization. In addition, TEMPO is expensive, toxic, can be absorbed through the skin, and has It is irritating and poses certain risks to experimenters, and its structure is unstable under acid and alkali conditions and is easy to decompose, resulting in many impurities in the product, making it difficult to recycle and easily polluting the environment. Therefore, this method is expensive and does not meet the current green and environmentally friendly chemical industry requirements.

Eric P.A.Talbot等于2017年发表在Org.Lett.(2017,19,870-873)的文献中描述了使用非金属催化氧化法将环状胺类化合物氧化生成内酰胺类化合物的方法。该方法使用了高达7.5当量的碘单质作为氧化剂,碘的价格较高,用量大,造成工艺成本高;且使用10当量的NaHCO3为pH值调节剂,产业化时会产生大量的固废,同样不利于绿色环保的化工要求。Eric PATalbot et al. published in Org. Lett. (2017, 19, 870-873) in 2017 described a method of using a non-metal catalytic oxidation method to oxidize cyclic amine compounds to generate lactam compounds. This method uses up to 7.5 equivalents of iodine element as the oxidant. The price of iodine is high and the dosage is large, resulting in high process costs; and 10 equivalents of NaHCO 3 are used as the pH adjuster, which will generate a large amount of solid waste during industrialization. It is also not conducive to the chemical industry requirements of green environmental protection.

上述工艺存在生产成本高、“三废”多、不环保、工艺放大时反应选择性差和反应不安全等缺点,不利于产业化生产。因此,对内酰胺类的化合物替代合成的研究具有十分重要的实用价值和意义。The above-mentioned process has shortcomings such as high production cost, high "three wastes", non-environmental protection, poor reaction selectivity and unsafe reaction during process amplification, which is not conducive to industrial production. Therefore, the study of alternative synthesis of lactam compounds has very important practical value and significance.

申请人于2019年申请的专利申请CN201911264060.3中,利用酸或酸式盐为pH值调节剂,亚氯酸钠为氧化剂,成功实现了利伐沙班中间体4-(4-氨基苯基)-3-吗啉酮的合成。具体地,该专利申请中提供一种合成4-(4-氨基苯基)-3-吗啉酮的方法,包括如下步骤:以对卤硝基苯和吗啉为起始物料,缩合生成4-(4-硝基苯基)吗啉,然后以亚卤酸盐或二氧化氯为氧化剂,通过酸或酸式盐调节控制反应体系pH值小于7,将4-(4-硝基苯基)吗啉氧化生成4-(4-硝基苯基)-3-吗啉酮,最后还原生成目标产物4-(4-氨基苯基)-3-吗啉酮。该合成方法表现出很好的应用价值。但在此方法中,pH控制较为困难。反应开始时,反应速度过快,放热较多,造成选择性较差,而反应后期,pH升高,反应速率降低。整个反应过程反应速度不太稳定。工艺放大时出现反应选择性差、反应不彻底等突出问题,不利于产业化生产。因此,对内酰胺类化合物的替代合成仍需要进一步改进。In the patent application CN201911264060.3 applied by the applicant in 2019, acid or acid salt was used as the pH regulator and sodium chlorite was used as the oxidant to successfully realize the rivaroxaban intermediate 4-(4-aminophenyl )-Synthesis of 3-morpholinone. Specifically, the patent application provides a method for synthesizing 4-(4-aminophenyl)-3-morpholinone, which includes the following steps: using p-halonitrobenzene and morpholine as starting materials, condensation to generate 4 -(4-nitrophenyl)morpholine, then use halide or chlorine dioxide as the oxidant, adjust the pH value of the reaction system with acid or acid salt to be less than 7, and convert 4-(4-nitrophenyl) ) morpholine is oxidized to generate 4-(4-nitrophenyl)-3-morpholinone, and finally reduced to generate the target product 4-(4-aminophenyl)-3-morpholinone. This synthesis method shows good application value. However, in this method, pH control is difficult. At the beginning of the reaction, the reaction speed is too fast and generates more heat, resulting in poor selectivity. In the later stage of the reaction, the pH increases and the reaction rate decreases. The reaction speed during the entire reaction process is unstable. When the process is scaled up, outstanding problems such as poor reaction selectivity and incomplete reactions occur, which is not conducive to industrial production. Therefore, the alternative synthesis of lactam compounds still needs further improvement.

发明内容Contents of the invention

针对内酰胺类化合物合成的上述不足,本发明的目的是提供一种绿色高效、反应条件温和、收率高且纯度高、后处理方便的易于工业化应用的内酰胺类化合物的合成方法。在本发明中,首次使用二氧化碳作为催化剂来参与氧化反应。二氧化碳是价廉易得的弱酸性气体,可以将反应体系pH值稳定控制在6左右,很好地控制了反应的进程和反应的选择性,是对现有技术的有效补充和极大改进。In view of the above-mentioned shortcomings in the synthesis of lactam compounds, the purpose of the present invention is to provide a synthetic method of lactam compounds that is green and efficient, has mild reaction conditions, has high yield and purity, and is convenient for post-processing and is easy for industrial application. In the present invention, carbon dioxide is used as a catalyst to participate in the oxidation reaction for the first time. Carbon dioxide is a cheap and easily available weakly acidic gas. It can stably control the pH value of the reaction system at around 6, well control the reaction process and reaction selectivity, and is an effective supplement and great improvement to the existing technology.

根据本发明的目的,本发明提供了一种内酰胺类化合物的合成方法,其特征在于,该方法使用亚氯酸钠为氧化剂,在二氧化碳催化下,将环状胺类化合物氧化为内酰胺类化合物。According to the purpose of the present invention, the present invention provides a method for synthesizing lactam compounds, which is characterized in that the method uses sodium chlorite as an oxidizing agent to oxidize cyclic amine compounds into lactam compounds under the catalysis of carbon dioxide. compound.

本发明合成内酰胺类化合物的方法中,并不局限于将特定结构的环状胺类化合物氧化为内酰胺类化合物,例如,专利申请CN201911264060.3中提到的将4-(4-硝基苯基)吗啉氧化为4-(4-硝基苯基)-3-吗啉酮。而作为本发明较为优选的方案,本发明的方法将如式II所示的环状胺类化合物氧化为如式I所示的内酰胺类化合物,化学反应方程式如下:The method for synthesizing lactam compounds of the present invention is not limited to oxidizing cyclic amine compounds with specific structures into lactam compounds. For example, the 4-(4-nitro group mentioned in patent application CN201911264060.3 Phenyl)morpholine is oxidized to 4-(4-nitrophenyl)-3-morpholinone. As a more preferred solution of the present invention, the method of the present invention oxidizes the cyclic amine compound represented by formula II into a lactam compound represented by formula I. The chemical reaction equation is as follows:

其中in

当n=0或1时,X为CH2,When n=0 or 1, X is CH2,

当n=2时,X为O或CH2When n=2, X is O or CH 2 ;

R为任选地被一个或多个选自氢、卤素、硝基、三氟甲基、氰基、C1-C6烷基、C1-C6酰基、C1-C6烷氧基取代的苯基、苄基、或吡啶基,其中“多个”是指被两个或两个以上的基团取代。R is optionally one or more selected from hydrogen, halogen, nitro, trifluoromethyl, cyano, C 1 -C 6 alkyl, C 1 -C 6 acyl, C 1 -C 6 alkoxy Substituted phenyl, benzyl, or pyridyl, where "multiple" means substituted by two or more groups.

作为一种示例,所述环状胺类化合物例如为4-(4-硝基苯基)吗啉、4-苯基吗啉、4-(2-甲基-4-硝基苯基)吗啉、4-(4-氰基苯基)吗啉、4-(2-氯-4-硝基苯基)吗啉、4-(4-硝基苄基)吗啉、4-(4-氯苯基)吗啉、4-(2-硝基-4-氰基苯基)吗啉、4-(吡啶-2-基)吗啉、4-(2-硝基-4-三氟甲基苯基)吗啉、4-(3-硝基-5-三氟甲基苯基)吗啉、1-(4-硝基苯基)哌啶、4-(3-硝基苯基)吗啉、1-(4-硝基苯基)四氢吡咯、1-(2-甲基苯基)哌啶、1-(3-氟-4-溴苯基)哌啶、1-(4-三氟甲基苯基)哌啶、1-(4-硝基苯基)吖丁啶等等。As an example, the cyclic amine compound is, for example, 4-(4-nitrophenyl)morpholine, 4-phenylmorpholine, 4-(2-methyl-4-nitrophenyl)morpholine 4-(4-cyanophenyl)morpholine, 4-(2-chloro-4-nitrophenyl)morpholine, 4-(4-nitrobenzyl)morpholine, 4-(4- Chlorophenyl)morpholine, 4-(2-nitro-4-cyanophenyl)morpholine, 4-(pyridin-2-yl)morpholine, 4-(2-nitro-4-trifluoromethyl methylphenyl)morpholine, 4-(3-nitro-5-trifluoromethylphenyl)morpholine, 1-(4-nitrophenyl)piperidine, 4-(3-nitrophenyl) Morpholine, 1-(4-nitrophenyl)tetrahydropyrrole, 1-(2-methylphenyl)piperidine, 1-(3-fluoro-4-bromophenyl)piperidine, 1-(4 -Trifluoromethylphenyl)piperidine, 1-(4-nitrophenyl)azetidine, etc.

本发明合成内酰胺类化合物的方法中,亚氯酸钠以亚氯酸钠水溶液的形式滴加入反应体系。In the method for synthesizing lactam compounds of the present invention, sodium chlorite is added dropwise to the reaction system in the form of sodium chlorite aqueous solution.

本发明合成内酰胺类化合物的方法中,反应体系中不加二氧化碳不反应,二氧化碳存在下能催化反应并快速进行。一方面,二氧化碳气体可以直接通入反应液面以下,也可以通入反应液面以上的反应容器内。另一方面,在滴加亚氯酸钠水溶液的过程中向反应体系连续性通入二氧化碳,滴毕后任选地向反应体系继续连续性通入二氧化碳、停止通入二氧化碳、或间断性地通入二氧化碳。上述任一种二氧化碳通入方式均可实现二氧化碳催化反应的目的,并且反应效果并无明显差异。In the method for synthesizing lactam compounds of the present invention, the reaction system does not react without adding carbon dioxide, but the reaction can be catalyzed and carried out rapidly in the presence of carbon dioxide. On the one hand, carbon dioxide gas can be directly introduced into the reaction vessel below the reaction liquid level, or into the reaction vessel above the reaction liquid level. On the other hand, during the process of dripping the sodium chlorite aqueous solution, carbon dioxide is continuously introduced into the reaction system. After the dripping is completed, carbon dioxide is optionally continued to be continuously introduced into the reaction system, carbon dioxide is stopped, or carbon dioxide is introduced intermittently. Enter carbon dioxide. Any of the above carbon dioxide introduction methods can achieve the purpose of carbon dioxide catalytic reaction, and there is no obvious difference in the reaction effect.

本发明合成内酰胺类化合物的方法中,环状胺类化合物与氧化剂亚氯酸钠的摩尔比为1∶1~1∶10,优选为1∶2~1∶6,例如,1∶2、1∶3、1∶4、1∶5、1∶6。亚氯酸钠作为一种稳定的氧化剂,广泛应用于工业领域,其来源易得,价格低廉,易溶于水,通过水洗分层后处理可以很容易的去除;此外,亚氯酸钠为碱金属盐,不会造成过渡重金属元素杂质超标的问题。In the method for synthesizing lactam compounds of the present invention, the molar ratio of the cyclic amine compound and the oxidant sodium chlorite is 1:1 to 1:10, preferably 1:2 to 1:6, for example, 1:2, 1:3, 1:4, 1:5, 1:6. As a stable oxidant, sodium chlorite is widely used in industrial fields. It is easily available, cheap, and soluble in water. It can be easily removed by washing and layering post-processing. In addition, sodium chlorite is an alkali. Metal salts will not cause the problem of excessive impurities of transition heavy metal elements.

本发明合成内酰胺类化合物的方法中,反应温度为0~100℃,优选为20~80℃,例如,反应温度可以是20℃、25℃、30℃、35℃、40℃、45℃、50℃、55℃、60℃、65℃、70℃、75℃、80℃。In the method for synthesizing lactam compounds of the present invention, the reaction temperature is 0-100°C, preferably 20-80°C. For example, the reaction temperature can be 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 50℃, 55℃, 60℃, 65℃, 70℃, 75℃, 80℃.

本发明合成内酰胺类化合物的方法中,所用的溶剂为腈类溶剂、醚类溶剂、甲苯、丙酮、二氯甲烷等非质子溶剂。腈类溶剂可选自乙腈、丙腈、丁腈等;醚类溶剂可选自四氢呋喃、2-甲基四氢呋喃、二氧六环等。In the method for synthesizing lactam compounds of the present invention, the solvents used are aprotic solvents such as nitrile solvents, ether solvents, toluene, acetone, and methylene chloride. Nitrile solvents can be selected from acetonitrile, propionitrile, butyronitrile, etc.; ether solvents can be selected from tetrahydrofuran, 2-methyltetrahydrofuran, dioxane, etc.

优选地,本发明提供了一种如式I所示的内酰胺类化合物的合成方法,该方法使用亚氯酸钠为氧化剂,在二氧化碳催化下,将如式II所示的环状胺类化合物氧化为如式I所示的内酰胺类化合物Preferably, the present invention provides a method for synthesizing lactam compounds represented by Formula I, which method uses sodium chlorite as an oxidizing agent to catalyze cyclic amine compounds represented by Formula II under carbon dioxide catalysis. Oxidized to lactam compounds as shown in formula I

其中in

当n=0或1时,X为CH2When n=0 or 1, X is CH 2 ,

当n=2时,X为O或CH2When n=2, X is O or CH 2 ;

R为任选地被一个或多个选自氢、卤素、硝基、三氟甲基、氰基、C1-C6烷基、C1-C6酰基、C1-C6烷氧基取代的苯基、苄基、或吡啶基,R is optionally one or more selected from hydrogen, halogen, nitro, trifluoromethyl, cyano, C 1 -C 6 alkyl, C 1 -C 6 acyl, C 1 -C 6 alkoxy substituted phenyl, benzyl, or pyridyl,

其中“多个”是指被两个或两个以上的基团取代,并且所述环状胺类化合物的种类、催化剂二氧化碳加入方式、环状胺类化合物与氧化剂亚氯酸钠的摩尔比、反应温度以及所用的溶剂如前所述。"Multiple" means substituted by two or more groups, and the type of the cyclic amine compound, the adding method of catalyst carbon dioxide, the molar ratio of the cyclic amine compound and the oxidant sodium chlorite, The reaction temperatures and solvents used were as described above.

本发明合成内酰胺类化合物的方法中,反应过程中在CO2催化下即可实现反应的高转化率和选择性。以CO2作为催化剂是申请人偶然意外发现,CO2本身作为一种自然界常见的气体,其应用也是多方面的,但未见其作为催化剂直接应用于氧化反应;CO2作为稳定的气体,其溶于水后生成碳酸,该反应本身也是可逆反应,生成的微量碳酸催化氧化反应的进行,在CO2催化下反应体系能够保持稳定的碳酸微环境,从而确保反应平稳温和的进行;此外,反应结束后,CO2即离开反应体系,减少了后处理步骤,且不会造成环境污染,更适合产业化应用。In the method for synthesizing lactam compounds of the present invention, high conversion rate and selectivity of the reaction can be achieved under CO 2 catalysis during the reaction process. Using CO 2 as a catalyst was the applicant's accidental discovery that CO 2 itself, as a common gas in nature, has many applications, but it has not been directly used as a catalyst in oxidation reactions; as a stable gas, CO 2 has After being dissolved in water, carbonic acid is generated. The reaction itself is also a reversible reaction. The generated trace amount of carbonic acid catalyzes the oxidation reaction. Under the catalysis of CO2 , the reaction system can maintain a stable carbonic acid microenvironment, thereby ensuring that the reaction proceeds smoothly and gently; in addition, the reaction After completion, CO 2 leaves the reaction system, which reduces post-processing steps and does not cause environmental pollution, making it more suitable for industrial applications.

本发明合成内酰胺类化合物的方法中,反应完成后,加入亚硫酸氢钠或亚硫酸钠等还原剂淬灭反应,浓缩回收溶剂,过滤水洗可得到内酰胺类化合物,收率可达85~98%,HPLC纯度最高可达99%以上。In the method of synthesizing lactam compounds of the present invention, after the reaction is completed, a reducing agent such as sodium bisulfite or sodium sulfite is added to quench the reaction, the solvent is concentrated and recovered, and the lactam compound can be obtained by filtering and washing with water, with a yield of up to 85 to 98%. , HPLC purity can reach up to 99% or more.

现有技术中,在采用非金属催化氧化法合成内酰胺类化合物时,文献当中的氧化方法不适合产业化应用。一方面使用了大量的氧化剂,造成了大量固废或者废液,提高了氧化成本,不环保;另一方面工艺放大时反应选择性差、反应不彻底等问题凸显,产物质量不高。In the prior art, when non-metal catalytic oxidation is used to synthesize lactam compounds, the oxidation methods in the literature are not suitable for industrial application. On the one hand, a large amount of oxidants are used, resulting in a large amount of solid waste or waste liquid, which increases the cost of oxidation and is not environmentally friendly; on the other hand, when the process is scaled up, problems such as poor reaction selectivity and incomplete reactions are highlighted, and the product quality is not high.

本发明合成内酰胺类化合物的方法具有显著的优点:使用亚氯酸钠为氧化剂,CO2作为催化剂,整个反应过程温和、可控,反应选择性高且反应彻底,产物收率高且纯度高。后处理方便简单,仅添加亚氯酸钠作为氧化剂,用量可控,氧化剂易溶于水,常规的水洗分层操作即可将其除去,避免了大量固废的产生;整个反应操作过程简单,产物易得,更加高效且绿色环保。The method for synthesizing lactam compounds of the present invention has significant advantages: sodium chlorite is used as the oxidant and CO2 is used as the catalyst. The entire reaction process is mild and controllable, the reaction selectivity is high and the reaction is thorough, and the product yield is high and the purity is high. . The post-treatment is convenient and simple. Only sodium chlorite is added as the oxidant. The dosage is controllable. The oxidant is easily soluble in water and can be removed by conventional water washing and layering operations, avoiding the generation of a large amount of solid waste. The entire reaction operation process is simple. Products are easily available, more efficient and green.

具体实施方式Detailed ways

下面结合具体实施例对本发明的实施方案进行详细描述,但是本领域技术人员应理解,实施例仅用于说明本发明,而不应视为限定本发明的范围。The embodiments of the present invention are described in detail below with reference to specific examples. However, those skilled in the art should understand that the examples are only used to illustrate the present invention and should not be regarded as limiting the scope of the present invention.

环状胺类化合物的制备可参考文献J.Org.Chem(2018,83,15333-15346)中描述的方法。The preparation of cyclic amine compounds can refer to the method described in J.Org.Chem (2018, 83, 15333-15346).

试剂和溶剂:均为市售商品;所用溶剂为国产分析纯试剂,均购自国药集团化学试剂有限公司,使用前均未经任何处理。市售亚氯酸钠为质量分数80%的固体,可以根据需要配制成质量浓度10~60%的水溶液,例如质量浓度为10%、20%、30%、40%、50%或60%的水溶液。Reagents and solvents: All are commercially available; the solvents used are domestic analytically pure reagents, purchased from Sinopharm Chemical Reagent Co., Ltd., and were not treated in any way before use. Commercially available sodium chlorite is a solid with a mass fraction of 80%. It can be prepared into an aqueous solution with a mass concentration of 10 to 60% as needed, such as a mass concentration of 10%, 20%, 30%, 40%, 50% or 60%. aqueous solution.

液相色谱:Agilent 1206。Liquid Chromatography: Agilent 1206.

核磁共振仪:Bruker DRX-400FT(Germany),1HNMR在CDCl3中测定,化学位移以四甲基硅烷(TMS)为基准,单位ppm。Nuclear magnetic resonance instrument: Bruker DRX-400FT (Germany), 1 HNMR was measured in CDCl 3 , the chemical shift was based on tetramethylsilane (TMS), and the unit was ppm.

实施例1:4-(4-硝基苯基)-3-吗啉酮合成Example 1: Synthesis of 4-(4-nitrophenyl)-3-morpholinone

100ml反应烧瓶中加入4-(4-硝基苯基)吗啉2.08g(0.01mol),20ml乙腈,升温至50℃,CO2存在下,将溶于5g水中的2.26g(0.02mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约3小时。反应完毕后,加入亚硫酸钠2.5g,室温搅拌10分钟。减压浓缩,得到黄色固体,加入30ml水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到4-(4-硝基苯基)-3-吗啉酮2.14g,收率96.4%,HPLC纯度99.7%。Add 2.08g (0.01mol) of 4-(4-nitrophenyl)morpholine and 20ml of acetonitrile to a 100ml reaction flask, heat it to 50°C, and in the presence of CO 2 , add 2.26g (0.02mol) of submers dissolved in 5g of water. Sodium chlorate is prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 3 hours. After the reaction is completed, add 2.5g of sodium sulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a yellow solid, add 30 ml of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, and dry to obtain 2.14 g of 4-(4-nitrophenyl)-3-morpholinone, yield 96.4%, HPLC purity 99.7%.

1HNMR(CDCl3,400MHz):δ8.21(d,J=8.8Hz,2H),7.55(d,J=9.2Hz,2H),4.31(s,2H),4.01(t,J=5.2Hz,2H),3.79(t,J=5.2Hz,2H). 1 HNMR (CDCl 3 , 400MHz): δ8.21 (d, J=8.8Hz, 2H), 7.55 (d, J=9.2Hz, 2H), 4.31 (s, 2H), 4.01 (t, J=5.2Hz , 2H), 3.79 (t, J=5.2Hz, 2H).

实施例2:4-苯基-3-吗啉酮合成Example 2: Synthesis of 4-phenyl-3-morpholinone

100ml反应烧瓶中加入4-苯基吗啉1.63g(0.01mol),20ml四氢呋喃,升温至60℃,CO2存在下,将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约1.5小时。反应完毕后,加入亚硫酸钠5g,室温搅拌15分钟。减压浓缩,得到淡黄色固体,加入25ml水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到4-苯基-3-吗啉酮1.53g,收率86.4%,HPLC纯度98.1%。Add 1.63g (0.01mol) of 4-phenylmorpholine and 20ml of tetrahydrofuran to a 100ml reaction flask, heat it to 60°C, and prepare 4.51g (0.04mol) of sodium chlorite dissolved in 14.16g of water in the presence of CO2 The aqueous solution was added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 1.5 hours. After the reaction is completed, add 5g of sodium sulfite and stir at room temperature for 15 minutes. Concentrate under reduced pressure to obtain a light yellow solid, add 25 ml of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, and obtain 1.53g of 4-phenyl-3-morpholinone after drying, yield 86.4%, HPLC purity 98.1%.

1HNMR(CDCl3,400MHz):δ7.48-7.36(m,2H),7.38-7.24(m,3H),4.35(s,2H),4.08-3.99(m,2H),3.82-3.72(m,2H). 1 HNMR (CDCl 3 , 400MHz): δ7.48-7.36(m, 2H), 7.38-7.24(m, 3H), 4.35(s, 2H), 4.08-3.99(m, 2H), 3.82-3.72(m ,2H).

实施例3:4-(2-甲基-4-硝基苯基)-3-吗啉酮合成Example 3: Synthesis of 4-(2-methyl-4-nitrophenyl)-3-morpholinone

100ml反应烧瓶中加入4-(2-甲基-4-硝基苯基)吗啉2.22g(0.01mol),25ml二氯甲烷,升温至30℃,CO2存在下,将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约3小时。反应完毕后,加入亚硫酸钠5g,室温搅拌10分钟。减压浓缩,得到淡黄色固体,加入30ml水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到4-(2-甲基-4-硝基苯基)-3-吗啉酮2.18g,收率92.4%,HPLC纯度98.9%。Add 2.22g (0.01mol) of 4-(2-methyl-4-nitrophenyl)morpholine and 25ml of methylene chloride into a 100ml reaction flask, heat it to 30°C, and dissolve it in 14.16g of water in the presence of CO 2 4.51g (0.04mol) of sodium chlorite was prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 3 hours. After the reaction is completed, add 5g of sodium sulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a light yellow solid. Add 30 ml of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, and dry to obtain 4-(2-methyl-4-nitrophenyl)-3-morpholine. Ketone 2.18g, yield 92.4%, HPLC purity 98.9%.

1HNMR(CDCl3,400MHz):δ8.22-8.10(m,2H),7.35(d,J=8.6Hz,1H),4.37(s,2H),4.08(s,2H),3.67(d,J=71.8Hz,2H),2.35(s,3H). 1 HNMR (CDCl 3 , 400MHz): δ8.22-8.10 (m, 2H), 7.35 (d, J=8.6Hz, 1H), 4.37 (s, 2H), 4.08 (s, 2H), 3.67 (d, J=71.8Hz, 2H), 2.35(s, 3H).

实施例4:4-(4-氰基苯基)-3-吗啉酮合成Example 4: Synthesis of 4-(4-cyanophenyl)-3-morpholinone

100ml反应烧瓶中加入4-(4-氰基苯基)吗啉1.88g(0.01mol),15ml二氧六环,升温至45℃,CO2存在下将溶于10.62g水中的3.38g(0.03mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约3小时,反应完毕后,加入亚硫酸钠3.8g,室温搅拌12分钟。减压浓缩,得到白色固体,加入25ml水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到4-(4-氰基苯基)-3-吗啉酮1.87g,收率92.6%,HPLC纯度98.1%。Add 1.88g (0.01mol) of 4-(4-cyanophenyl)morpholine and 15ml of dioxane into a 100ml reaction flask, heat it to 45°C, and dissolve 3.38g (0.03g) of 10.62g of water in the presence of CO2 mol) sodium chlorite was prepared into an aqueous solution and added dropwise to the reaction system. After the dropping is completed, continue the reaction for about 3 hours. After the reaction is completed, add 3.8g of sodium sulfite and stir at room temperature for 12 minutes. Concentrate under reduced pressure to obtain a white solid, add 25 ml of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, and dry to obtain 1.87 g of 4-(4-cyanophenyl)-3-morpholinone, yield 92.6%, HPLC purity 98.1%.

1HNMR(CDCl3,400MHz):δ7.75-7.67(m,2H),7.59-7.50(m,2H),4.36(s,2H),4.10-4.03(m,2H),3.86-3.78(m,2H). 1 HNMR (CDCl 3 , 400MHz): δ7.75-7.67(m, 2H), 7.59-7.50(m, 2H), 4.36(s, 2H), 4.10-4.03(m, 2H), 3.86-3.78(m ,2H).

实施例5:4-(2-氯-4-硝基苯基)-3-吗啉酮合成Example 5: Synthesis of 4-(2-chloro-4-nitrophenyl)-3-morpholinone

100ml反应烧瓶中加入4-(2-氯-4-硝基苯基)吗啉2.42g(0.01mol),25ml甲苯,升温至80℃,CO2存在下,将溶于10.62g水中的3.38g(0.03mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约5小时。反应完毕后,加入亚硫酸钠3.8g,室温搅拌15分钟。减压浓缩,得到淡黄色固体,加入40ml水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到4-(2-氯-4-硝基苯基)-3-吗啉酮2.51g,收率98.0%,HPLC纯度99.1%。Add 2.42g (0.01mol) of 4-(2-chloro-4-nitrophenyl)morpholine and 25ml of toluene to the 100ml reaction flask, heat it to 80°C, and in the presence of CO 2 , dissolve 3.38g of 4-(2-chloro-4-nitrophenyl)morpholine in 10.62g of water. (0.03mol) sodium chlorite was prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 5 hours. After the reaction is completed, add 3.8g of sodium sulfite and stir at room temperature for 15 minutes. Concentrate under reduced pressure to obtain a light yellow solid. Add 40 ml of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, and dry to obtain 4-(2-chloro-4-nitrophenyl)-3-morpholinone. 2.51g, yield 98.0%, HPLC purity 99.1%.

1HNMR(CDCl3,400MHz):δ8.42(d,J=2.5Hz,1H),8.24(dd,J=8.7,2.5Hz,1H),7.54(d,J=8.6Hz,1H),4.41(s,2H),4.11(dd,J=5.8,4.2Hz,2H),3.74(t,J=5.0Hz,2H). 1 HNMR (CDCl 3 , 400MHz): δ8.42 (d, J=2.5Hz, 1H), 8.24 (dd, J=8.7, 2.5Hz, 1H), 7.54 (d, J=8.6Hz, 1H), 4.41 (s, 2H), 4.11 (dd, J=5.8, 4.2Hz, 2H), 3.74 (t, J=5.0Hz, 2H).

实施例6:4-(4-氯苯基)-3-吗啉酮合成Example 6: Synthesis of 4-(4-chlorophenyl)-3-morpholinone

100ml反应烧瓶中加入4-(4-氯苯基)吗啉1.98g(0.01mol),20ml丙酮,升温至20℃,CO2存在下,将溶于8.35g水中的5.65g(0.05mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约2.5小时。反应完毕后,加入亚硫酸钠6.3g,室温搅拌10分钟。减压浓缩,得到淡黄色固体,加入50ml水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到4-(4-氯苯基)-3-吗啉酮1.81g,收率85.4%,HPLC纯度98.1%。Add 1.98g (0.01mol) of 4-(4-chlorophenyl)morpholine and 20ml of acetone into a 100ml reaction flask, heat it to 20°C, and in the presence of CO 2 , add 5.65g (0.05mol) of submers dissolved in 8.35g of water. Sodium chlorate is prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 2.5 hours. After the reaction is completed, add 6.3g of sodium sulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a light yellow solid, add 50 ml of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, and dry to obtain 1.81 g of 4-(4-chlorophenyl)-3-morpholinone, yield 85.4%, HPLC purity 98.1%.

1HNMR(CDCl3,400MHz):δ7.43-7.32(m,2H),7.32-7.26(m,2H),4.34(s,2H),4.07-4.00(m,2H),3.79-3.71(m,2H). 1 HNMR (CDCl 3 , 400MHz): δ7.43-7.32(m, 2H), 7.32-7.26(m, 2H), 4.34(s, 2H), 4.07-4.00(m, 2H), 3.79-3.71(m ,2H).

实施例7:4-(2-硝基-4-氰基苯基)-3-吗啉酮合成Example 7: Synthesis of 4-(2-nitro-4-cyanophenyl)-3-morpholinone

100ml反应烧瓶中加入4-(2-硝基-4-氰基苯基)吗啉2.33g(0.0lmol),35ml丙腈,升温至55℃,CO2存在下,将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约6小时。反应完毕后,加入亚硫酸氢钠4.2g,室温搅拌10分钟。减压浓缩,得到黄色固体,加入30ml水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到4-(2-硝基-4-氰基苯基)-3-吗啉酮2.42g,收率98.0%,HPLC纯度99.1%。Add 2.33g (0.0lmol) of 4-(2-nitro-4-cyanophenyl)morpholine and 35ml of propionitrile to a 100ml reaction flask, heat it to 55°C, and in the presence of CO2 , dissolve 14.16g of water 4.51g (0.04mol) sodium chlorite was prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 6 hours. After the reaction is completed, add 4.2g of sodium bisulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a yellow solid. Add 30 ml of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, and dry to obtain 4-(2-nitro-4-cyanophenyl)-3-morpholinone. 2.42g, yield 98.0%, HPLC purity 99.1%.

1HNMR(CDCl3,400MHz):δ8.30(d,J=1.9Hz,1H),7.97(dd,J=8.3,1.9Hz,1H),7.54(d,J=8.3Hz,1H),4.33(s,2H),4.12(t,J=5.0Hz,2H),3.87(s,2H). 1 HNMR (CDCl 3 , 400MHz): δ8.30 (d, J=1.9Hz, 1H), 7.97 (dd, J=8.3, 1.9Hz, 1H), 7.54 (d, J=8.3Hz, 1H), 4.33 (s, 2H), 4.12 (t, J=5.0Hz, 2H), 3.87 (s, 2H).

实施例8:4-(2-硝基-4-三氟甲基苯基)-3-吗啉酮合成Example 8: Synthesis of 4-(2-nitro-4-trifluoromethylphenyl)-3-morpholinone

100ml反应烧瓶中加入4-(2-硝基-4-三氟甲基苯基)吗啉2.76g(0.01mol),40ml丁腈,升温至65℃,CO2存在下,将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约4小时。反应完毕后,加入亚硫酸氢钠4.2g,室温搅拌10分钟。减压浓缩,得到淡黄色固体,加入20ml水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到4-(2-硝基-4-三氟甲基苯基)-3-吗啉酮2.85g,收率98.3%,HPLC纯度99.1%。Add 2.76g (0.01mol) of 4-(2-nitro-4-trifluoromethylphenyl)morpholine and 40ml of butyronitrile to a 100ml reaction flask, heat it to 65°C, and dissolve 14.16g of it in the presence of CO2 4.51g (0.04mol) sodium chlorite in water was prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 4 hours. After the reaction is completed, add 4.2g of sodium bisulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a light yellow solid. Add 20 ml of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, and dry to obtain 4-(2-nitro-4-trifluoromethylphenyl)-3- Morlinone 2.85g, yield 98.3%, HPLC purity 99.1%.

1HNMR(CDCl3,400MHz):δ8.29(d,J=2.0Hz,1H),7.96(ddd,J=8.3,2.0,0.7Hz,1H),7.56(dd,J=8.3,0.9Hz,1H),4.33(s,2H),4.12(t,J=5.0Hz,2H),3.87(s,2H). 1 HNMR (CDCl 3 , 400MHz): δ8.29 (d, J=2.0Hz, 1H), 7.96 (ddd, J=8.3, 2.0, 0.7Hz, 1H), 7.56 (dd, J=8.3, 0.9Hz, 1H), 4.33(s, 2H), 4.12(t, J=5.0Hz, 2H), 3.87(s, 2H).

实施例9:4-(3-硝基-5-三氟甲基苯基)-3-吗啉酮合成Example 9: Synthesis of 4-(3-nitro-5-trifluoromethylphenyl)-3-morpholinone

100ml反应烧瓶中加入4-(3-硝基-5-三氟甲基苯基)吗啉2.76g(0.01mol),40ml2-甲基四氢呋喃,升温至60℃,CO2存在下,将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约4.5小时。反应完毕后,加入亚硫酸钠5g,室温搅拌10分钟。减压浓缩,得到淡黄色固体,加入35ml水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到4-(3-硝基-5-三氟甲基苯基)-3-吗啉酮2.82g,收率97.2%,HPLC纯度99.1%。Add 2.76g (0.01mol) of 4-(3-nitro-5-trifluoromethylphenyl)morpholine and 40ml of 2-methyltetrahydrofuran to a 100ml reaction flask, and heat it to 60°C. In the presence of CO 2 , dissolve in 4.51g (0.04mol) sodium chlorite in 14.16g water was prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 4.5 hours. After the reaction is completed, add 5g of sodium sulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a light yellow solid. Add 35 ml of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, and dry to obtain 4-(3-nitro-5-trifluoromethylphenyl)-3- Morlinone 2.82g, yield 97.2%, HPLC purity 99.1%.

1HNMR(CDCl3,400MHz):δ8.49(s,J=2.1Hz,1H),8.38(s,1H),8.10(s,1H),4.40(s,2H),4.15-4.07(m,2H),3.91(dd,J=5.9,4.1Hz,2H).1HNMR (CDCl 3 , 400MHz): δ8.49 (s, J=2.1Hz, 1H), 8.38 (s, 1H), 8.10 (s, 1H), 4.40 (s, 2H), 4.15-4.07 (m, 2H ), 3.91 (dd, J=5.9, 4.1Hz, 2H).

实施例10:1-(4-硝基苯基)-2-哌啶酮合成Example 10: Synthesis of 1-(4-nitrophenyl)-2-piperidone

100ml反应烧瓶中加入1-(4-硝基苯基)哌啶2.06g(0.01mol),30ml丁腈,升温至55℃,CO2存在下,将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约3小时。反应完毕后,加入亚硫酸氢钠4.2g,室温搅拌10分钟。减压浓缩,得到淡黄色固体,加入30ml水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到1-(4-硝基苯基)-2-哌啶酮1.98g,收率90.0%,HPLC纯度98%。Add 2.06g (0.01mol) of 1-(4-nitrophenyl)piperidine and 30ml of butyronitrile to a 100ml reaction flask, heat it to 55°C, and in the presence of CO2 , dissolve 4.51g (0.04mol) of 14.16g of water. ) Sodium chlorite is prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 3 hours. After the reaction is completed, add 4.2g of sodium bisulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a light yellow solid, add 30 ml of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, dry to obtain 1.98 g of 1-(4-nitrophenyl)-2-piperidone, and collect The yield is 90.0% and the HPLC purity is 98%.

1HNMR(CDCl3,400MHz):δ8.29-8.20(m,2H),7.53-7.45(m,2H),3.77-3.69(m,2H),2.61(t,J=6.5Hz,2H),2.07-1.92(m,4H). 1 HNMR (CDCl 3 , 400MHz): δ 8.29-8.20 (m, 2H), 7.53-7.45 (m, 2H), 3.77-3.69 (m, 2H), 2.61 (t, J=6.5Hz, 2H), 2.07-1.92(m,4H).

实施例11:1-(4-硝基苯基)-2-四氢吡咯烷酮合成Example 11: Synthesis of 1-(4-nitrophenyl)-2-tetrahydropyrrolidone

100ml反应烧瓶中加入1-(4-硝基苯基)四氢吡咯1.92g(0.01mol),30ml二氯甲烷,升温至30℃,CO2存在下,将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约6小时。反应完毕后,加入亚硫酸钠5g,室温搅拌10分钟。减压浓缩,得到淡黄色固体,加入35ml水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到1-(4-硝基苯基)-2-四氢吡咯烷酮2.02g,收率98.1%,HPLC纯度99.1%。Add 1.92g (0.01mol) of 1-(4-nitrophenyl)tetrahydropyrrole and 30ml of methylene chloride to the 100ml reaction flask, heat it to 30°C, and in the presence of CO 2 , dissolve 4.51g (0.01mol) of 14.16g of water. 0.04mol) sodium chlorite was prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 6 hours. After the reaction is completed, add 5g of sodium sulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a light yellow solid, add 35 ml of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, dry to obtain 2.02 g of 1-(4-nitrophenyl)-2-tetrahydropyrrolidone, and collect The yield is 98.1% and the HPLC purity is 99.1%.

1HNMR(CDCl3,400MHz):δ8.28-8.19(m,2H),7.89-7.81(m,2H),3.93(t,J=7.1Hz,2H),2.68(dd,J=8.6,7.7Hz,2H),2.23(tt,J=7.8,6.9Hz,2H). 1 HNMR (CDCl 3 , 400MHz): δ 8.28-8.19 (m, 2H), 7.89-7.81 (m, 2H), 3.93 (t, J=7.1Hz, 2H), 2.68 (dd, J=8.6, 7.7 Hz, 2H), 2.23 (tt, J=7.8, 6.9Hz, 2H).

实施例12:1-(4-硝基苯基)-吖丁啶-2-酮合成Example 12: Synthesis of 1-(4-nitrophenyl)-azetidin-2-one

100ml反应烧瓶中加入1-(4-硝基苯基)吖丁啶1.78g(0.01mol),25ml四氢呋喃,升温至45℃,CO2存在下,将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约2.5小时。反应完毕后,加入亚硫酸氢钠4.2g,室温搅拌10分钟。减压浓缩,得到黄色固体,加入25ml水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到1-(4-硝基苯基)-吖丁啶-2-酮1.68g,收率87.5%,HPLC纯度99.1%。Add 1.78g (0.01mol) of 1-(4-nitrophenyl) azetidine and 25ml of tetrahydrofuran to the 100ml reaction flask, and heat it to 45°C. In the presence of CO 2 , dissolve 4.51g (0.04mol) of 14.16g of water. ) Sodium chlorite is prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 2.5 hours. After the reaction is completed, add 4.2g of sodium bisulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a yellow solid, add 25 ml of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, and dry to obtain 1.68g of 1-(4-nitrophenyl)-azetidin-2-one. The yield was 87.5%, and the HPLC purity was 99.1%.

1HNMR(CDCl3,400MHz):δ8.30-8.22(m,2H),7.51-7.43(m,2H),3.76(t,J=4.7Hz,2H),3.25(t,J=4.7Hz,2H). 1 HNMR (CDCl 3 , 400MHz): δ 8.30-8.22 (m, 2H), 7.51-7.43 (m, 2H), 3.76 (t, J=4.7Hz, 2H), 3.25 (t, J=4.7Hz, 2H).

实施例13:1-(3-氟-4-溴苯基)哌啶-2-酮合成Example 13: Synthesis of 1-(3-fluoro-4-bromophenyl)piperidin-2-one

100ml反应烧瓶中加入1-(3-氟-4-溴苯基)哌啶2.57g(0.01mol),40ml甲苯,升温至80℃,CO2存在下,将溶于5g水中的2.26g(0.02mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约3小时。反应完毕后,加入亚硫酸钠2.5g,室温搅拌10分钟。减压浓缩,加入20ml水,二氯甲烷(20ml*3)萃取,合并有机相,浓缩得到无色油状物1-(3-氟-4-溴苯基)哌啶-2-酮2.33g,收率85.7%,HPLC纯度99.3%。Add 2.57g (0.01mol) of 1-(3-fluoro-4-bromophenyl)piperidine and 40ml of toluene into the 100ml reaction flask, heat it to 80°C, and in the presence of CO2 , dissolve 2.26g (0.02g) of 1-(3-fluoro-4-bromophenyl)piperidine in 5g of water. mol) sodium chlorite was prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 3 hours. After the reaction is completed, add 2.5g of sodium sulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure, add 20ml of water, extract with dichloromethane (20ml*3), combine the organic phases, and concentrate to obtain 2.33g of colorless oily substance 1-(3-fluoro-4-bromophenyl)piperidin-2-one. The yield was 85.7%, and the HPLC purity was 99.3%.

1HNMR(CDCl3,400MHz):δ7.55(t,J=8.1Hz,1H),7.16-7.09(m,1H),6.99(dd,J=8.5,2.3Hz,1H),3.64(t,J=5.5Hz,2H),2.57(t,J=6.3Hz,2H),2.03-1.88(m,4H). 1 HNMR (CDCl 3 , 400MHz): δ7.55 (t, J=8.1Hz, 1H), 7.16-7.09 (m, 1H), 6.99 (dd, J=8.5, 2.3Hz, 1H), 3.64 (t, J=5.5Hz, 2H), 2.57(t, J=6.3Hz, 2H), 2.03-1.88(m, 4H).

实施例14:1-(4-三氟甲基苯基)哌啶-2-酮合成Example 14: Synthesis of 1-(4-trifluoromethylphenyl)piperidin-2-one

100ml反应烧瓶中加入1-(4-三氟甲基苯基)哌啶2.29g(0.01mol),40ml丙腈,升温至65℃,CO2存在下,将溶于10.62g水中的3.38g(0.03mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约1.5小时。反应完毕后,加入亚硫酸钠3.8g,室温搅拌10分钟。减压浓缩,得到黄色固体,加入60ml水,搅拌20分钟后过滤,干燥,得到白色固体1-(4-三氟甲基苯基)哌啶-2-酮2.17g,收率89.3%,HPLC纯度99.6%。Add 2.29g (0.01mol) of 1-(4-trifluoromethylphenyl)piperidine and 40ml of propionitrile to the 100ml reaction flask, heat it to 65°C, and in the presence of CO 2 , dissolve 3.38g (0.01mol) of 10.62g of water. 0.03mol) sodium chlorite was prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 1.5 hours. After the reaction is completed, add 3.8g of sodium sulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a yellow solid, add 60 ml of water, stir for 20 minutes, filter and dry to obtain 2.17g of white solid 1-(4-trifluoromethylphenyl)piperidin-2-one, yield 89.3%, HPLC Purity 99.6%.

1HNMR(CDCl3,400MHz):δ7.66(t,J=8.3Hz,2H),7.42(d,J=8.2Hz,2H),3.69(t,J=5.5Hz,2H),2.60(t,J=6.3Hz,2H),2.00(ddt,J=11.7,8.54.5Hz,4H). 1 HNMR (CDCl 3 , 400MHz): δ7.66 (t, J=8.3Hz, 2H), 7.42 (d, J=8.2Hz, 2H), 3.69 (t, J=5.5Hz, 2H), 2.60 (t , J=6.3Hz, 2H), 2.00 (ddt, J=11.7, 8.54.5Hz, 4H).

实施例15:4-(3-硝基苯基)-3-吗啉酮合成Example 15: Synthesis of 4-(3-nitrophenyl)-3-morpholinone

100ml反应烧瓶中加入4-(3-硝基苯基)吗啉2.08g(0.01mol),20ml二氨甲烷,升温至30℃,CO2存在下,将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约5小时。反应完毕后,加入亚硫酸钠5g,室温搅拌10分钟。减压浓缩,得到黄色固体,加入25ml水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到黄色固体4-(3-硝基苯基)-3-吗啉酮2.01g,收率90.5%,HPLC纯度99.7%。Add 2.08g (0.01mol) of 4-(3-nitrophenyl)morpholine and 20ml of dihydromethane into the 100ml reaction flask, heat it to 30°C, and in the presence of CO2 , dissolve 4.51g (0.04 mol) sodium chlorite was prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 5 hours. After the reaction is completed, add 5g of sodium sulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a yellow solid, add 25 ml of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, and dry to obtain 2.01 g of 4-(3-nitrophenyl)-3-morpholinone as a yellow solid. The yield was 90.5%, and the HPLC purity was 99.7%.

1HNMR(CDCl3,400MHz):δ8.27(t,J=2.2Hz,1H),8.16(ddd,J=8.2,2.2,1.0Hz,1H),7.82(ddd,J=8.1,2.1,1.0Hz,1H),7.62(t,J=8.1Hz,1H),4.40(s,2H),4.11(dd,J=5.9,4.1Hz,2H),3.88(dd,J=5.9,4.1Hz,2H). 1 HNMR (CDCl 3 , 400MHz): δ8.27 (t, J=2.2Hz, 1H), 8.16 (ddd, J=8.2, 2.2, 1.0Hz, 1H), 7.82 (ddd, J=8.1, 2.1, 1.0 Hz, 1H), 7.62 (t, J=8.1Hz, 1H), 4.40 (s, 2H), 4.11 (dd, J=5.9, 4.1Hz, 2H), 3.88 (dd, J=5.9, 4.1Hz, 2H ).

实施例16:4-(吡啶-2-基)-3-吗啉酮合成Example 16: Synthesis of 4-(pyridin-2-yl)-3-morpholinone

100ml反应烧瓶中加入4-(吡啶-2-基)吗啉酮1.64g(0.01mol),25ml二氧六环,升温至40℃,CO2存在下,将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约5.5小时。反应完毕后,加入亚硫酸钠5g,室温搅拌10分钟。减压浓缩,得到黄色固体,加入35ml水,搅拌20分钟,过滤,干燥,得到白色固体4-(吡啶-2-基)-3-吗啉酮1.52g,收率85.4%,HPLC纯度99.6%。Add 1.64g (0.01mol) of 4-(pyridin-2-yl)morpholinone and 25ml of dioxane to the 100ml reaction flask, heat it to 40°C, and in the presence of CO2 , dissolve 4.51g ( 0.04mol) sodium chlorite was prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 5.5 hours. After the reaction is completed, add 5g of sodium sulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a yellow solid, add 35 ml of water, stir for 20 minutes, filter, and dry to obtain 1.52 g of white solid 4-(pyridin-2-yl)-3-morpholinone, yield 85.4%, HPLC purity 99.6% .

1HNMR(CDCl3,400MHz):δ8.44(dd,J=5.0,1.9Hz,1H),8.11(dt,J=8.3,1.0Hz,1H),7.73(ddd,J=8.4,7.3,2.0Hz,1H),7.13(ddd,J=7.3,4.9,1.0Hz,1H),4.37(s,2H),4.16-4.09(m,2H),4.09-4.02(m,2H). 1 HNMR (CDCl 3 , 400MHz): δ8.44 (dd, J=5.0, 1.9Hz, 1H), 8.11 (dt, J=8.3, 1.0Hz, 1H), 7.73 (ddd, J=8.4, 7.3, 2.0 Hz, 1H), 7.13 (ddd, J=7.3, 4.9, 1.0Hz, 1H), 4.37 (s, 2H), 4.16-4.09 (m, 2H), 4.09-4.02 (m, 2H).

实施例17:4-(4-硝基苄基)-3-吗啉酮合成Example 17: Synthesis of 4-(4-nitrobenzyl)-3-morpholinone

100ml反应烧瓶中加入4-(4-硝基苄基)吗啉2.22g(0.01mol),20ml 2-甲基四氢呋喃,升温至50℃,CO2存在下,将溶于10.62g水中的3.38g(0.03mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约5小时。反应完毕后,加入亚硫酸钠3.8g,室温搅拌10分钟。减压浓缩,得到黄色固体,加入25ml水,搅拌20分钟后,减压浓缩,得到淡黄色固体4-(4-硝基苄基)-3-吗啉酮2.04g,收率86.4%,HPLC纯度98.3%。Add 2.22g (0.01mol) of 4-(4-nitrobenzyl)morpholine and 20ml of 2-methyltetrahydrofuran to the 100ml reaction flask, heat it to 50°C, and in the presence of CO2 , dissolve 3.38g of 10.62g of water. (0.03mol) sodium chlorite was prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 5 hours. After the reaction is completed, add 3.8g of sodium sulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a yellow solid, add 25 ml of water, stir for 20 minutes, and concentrate under reduced pressure to obtain 2.04 g of light yellow solid 4-(4-nitrobenzyl)-3-morpholinone, yield 86.4%, HPLC Purity 98.3%.

1HNMR(CDCl3,400MHz):δ8.24(dd,J=9.0,2.1Hz,2H),7.51-7.44(m,2H),4.74(s,2H),4.30(s,2H),3.95-3.87(m,2H),3.35(dd,J=5.9,4.4Hz,2H). 1 HNMR (CDCl 3 , 400MHz): δ8.24 (dd, J=9.0, 2.1Hz, 2H), 7.51-7.44 (m, 2H), 4.74 (s, 2H), 4.30 (s, 2H), 3.95- 3.87 (m, 2H), 3.35 (dd, J=5.9, 4.4Hz, 2H).

实施例18:1-(2-甲基苯基)哌啶-2-酮合成Example 18: Synthesis of 1-(2-methylphenyl)piperidin-2-one

100ml反应烧瓶中加入1-(2-甲基苯基)哌啶1.75g(0.01mol),25ml丙酮,升温至30℃,CO2存在下,将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约4.5小时。反应完毕后,加入亚硫酸钠5g,室温搅拌10分钟。减压浓缩,得到黄色固体,加入30ml水,搅拌20分钟,过滤,干燥,得到白色固体1-(2-甲基苯基)哌啶-2-酮1.66g,收率87.8%,HPLC纯度99.3%。Add 1.75g (0.01mol) of 1-(2-methylphenyl)piperidine and 25ml of acetone into the 100ml reaction flask, heat it to 30°C, and in the presence of CO 2 , dissolve 4.51g (0.04mol) in 14.16g of water. Sodium chlorite is prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 4.5 hours. After the reaction is completed, add 5g of sodium sulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a yellow solid, add 30 ml of water, stir for 20 minutes, filter and dry to obtain 1.66g of white solid 1-(2-methylphenyl)piperidin-2-one, yield 87.8%, HPLC purity 99.3 %.

1HNMR(CDCl3,400MHz):δ7.32-7.29(m,1H),7.27-7.22(m,2H),7.15-7.10(m,1H),4.66-4.57(m,2H),2.48-2.36(m,4H),2.26(s,3H),1.96(m,2H). 1 HNMR (CDCl 3 , 400MHz): δ7.32-7.29 (m, 1H), 7.27-7.22 (m, 2H), 7.15-7.10 (m, 1H), 4.66-4.57 (m, 2H), 2.48-2.36 (m, 4H), 2.26 (s, 3H), 1.96 (m, 2H).

实施例19:4-(3-硝基苯基)-3-吗啉酮合成Example 19: Synthesis of 4-(3-nitrophenyl)-3-morpholinone

100mL反应烧瓶中加入4-(3-硝基苯基)吗啉2.08g(0.01mol),20mL二氯甲烷,升温至30℃,向体系中通入CO2,同时将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,停止通入CO2,继续反应约5小时。反应完毕后,加入亚硫酸钠5g,室温搅拌10分钟。减压浓缩,得到黄色固体,加入25mL水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到黄色固体4-(3-硝基苯基)-3-吗啉酮2.05g,收率92.3%,HPLC纯度99.7%。Add 2.08g (0.01mol) of 4-(3-nitrophenyl)morpholine and 20mL of methylene chloride into the 100mL reaction flask, raise the temperature to 30°C, pass CO 2 into the system, and at the same time dissolve 14.16g of water. 4.51g (0.04mol) sodium chlorite was prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the flow of CO 2 is stopped and the reaction is continued for about 5 hours. After the reaction is completed, add 5g of sodium sulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a yellow solid, add 25 mL of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, and dry to obtain 2.05 g of 4-(3-nitrophenyl)-3-morpholinone as a yellow solid. The yield was 92.3%, and the HPLC purity was 99.7%.

实施例20:4-(3-硝基苯基)-3-吗啉酮合成Example 20: Synthesis of 4-(3-nitrophenyl)-3-morpholinone

100mL反应烧瓶中加入4-(3-硝基苯基)吗啉2.08g(0.01mol),20mL二氯甲烷,升温至30℃,向体系通入CO2,在同时将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,停止通入CO2,继续反应约5小时,期间间断性地通入CO2。反应完毕后,加入亚硫酸钠5g,室温搅拌10分钟。减压浓缩,得到黄色固体,加入25mL水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到黄色固体4-(3-硝基苯基)-3-吗啉酮2.03g,收率91.4%,HPLC纯度99.6%。Add 2.08g (0.01mol) of 4-(3-nitrophenyl)morpholine and 20mL of methylene chloride into the 100mL reaction flask, raise the temperature to 30°C, introduce CO 2 into the system, and at the same time, dissolve 14.16g of water into the reaction flask. 4.51g (0.04mol) sodium chlorite was prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the flow of CO 2 is stopped, and the reaction is continued for about 5 hours, during which time CO 2 is flowed in intermittently. After the reaction is completed, add 5g of sodium sulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a yellow solid, add 25 mL of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, and dry to obtain 2.03 g of 4-(3-nitrophenyl)-3-morpholinone as a yellow solid. The yield was 91.4%, and the HPLC purity was 99.6%.

对比实施例1:4-(3-硝基苯基)-3-吗啉酮合成Comparative Example 1: Synthesis of 4-(3-nitrophenyl)-3-morpholinone

与实施例15对比,不加催化剂CO2Compared with Example 15, no catalyst CO 2 was added.

100mL反应烧瓶中加入4-(3-硝基苯基)吗啉2.08g(0.01mol),20mL二氯甲烷,升温至30℃,将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约8小时后,加入亚硫酸钠5g,室温搅拌10分钟。减压浓缩,得到黄色固体,加入25mL水,搅拌20分钟后,过滤,用适量水洗涤滤饼,干燥后得到黄色固体4-(3-硝基苯基)-3-吗啉酮0.81g,收率36.47%,HPLC纯度20.8%。Add 2.08g (0.01mol) of 4-(3-nitrophenyl)morpholine and 20mL of methylene chloride into a 100mL reaction flask, heat it to 30°C, and dissolve 4.51g (0.04mol) of chlorous acid in 14.16g of water. Sodium is prepared into an aqueous solution and added dropwise to the reaction system. After the dropping is completed and the reaction is continued for about 8 hours, 5g of sodium sulfite is added and stirred at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a yellow solid, add 25 mL of water, stir for 20 minutes, filter, wash the filter cake with an appropriate amount of water, and dry to obtain 0.81 g of 4-(3-nitrophenyl)-3-morpholinone as a yellow solid. The yield is 36.47%, and the HPLC purity is 20.8%.

对比实施例2:4-(吡啶-2-基)-3-吗啉酮合成Comparative Example 2: Synthesis of 4-(pyridin-2-yl)-3-morpholinone

与实施例16对比,催化剂由CO2换成甲酸。Compared with Example 16, the catalyst was changed from CO 2 to formic acid.

100mL反应烧瓶中加入4-(吡啶-2-基)吗啉酮1.64g(0.01mol),25mL二氧六环,甲酸0.27g(0.006mol),升温至40℃,将溶于14.16g水中的4.51g(0.04mol)亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约6小时。反应完毕后,加入亚硫酸钠5g,室温搅拌10分钟。减压浓缩,得到黄色固体,加入35mL水,搅拌20分钟,过滤,干燥,得到白色固体4-(吡啶-2-基)-3-吗啉酮1.42g,收率79.8%,HPLC纯度91.6%。Add 1.64g (0.01mol) of 4-(pyridin-2-yl)morpholinone, 25mL of dioxane, and 0.27g of formic acid (0.006mol) into a 100mL reaction flask, heat it to 40°C, and dissolve the 4.51g (0.04mol) sodium chlorite was prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction continues for about 6 hours. After the reaction is completed, add 5g of sodium sulfite and stir at room temperature for 10 minutes. Concentrate under reduced pressure to obtain a yellow solid, add 35 mL of water, stir for 20 minutes, filter, and dry to obtain 1.42 g of white solid 4-(pyridin-2-yl)-3-morpholinone, yield 79.8%, HPLC purity 91.6% .

对比实施例3:4-(3-硝基苯基)-3-吗啉酮合成Comparative Example 3: Synthesis of 4-(3-nitrophenyl)-3-morpholinone

根据CN201911264060.3放大。Amplified according to CN201911264060.3.

反应釜中加入4-(3-硝基苯基)吗啉104g(0.5mol),二水合磷酸二氢钠234g,3L乙腈,升温至40℃,将溶于650g水中的169g 80%亚氯酸钠配制成水溶液滴加入反应体系。滴毕,继续反应约6小时,HPLC监控反应。反应结束后,静置分层,收集有机层,水层加700mL乙酸乙酯萃取两次,合并有机层,并置于冷水浴中,加入约1L饱和亚硫酸钠水溶液,搅拌10分钟,水相加500mL乙酸乙酯萃取2次,再次合并有机相,加入无水硫酸钠干燥,减压浓缩,得到黄色固体,加入240mL混合溶剂(石油醚∶乙酸乙酯=5∶1(V∶V)),充分搅拌20分钟,处理得到黄色固体106g,收率95.9%,HPLC纯度95.7%,原料约3.1%,最大杂质1.1%。反应6小时时反应液纯度83.8%,原料约5.11%,最大杂质2.6%。Add 104g (0.5mol) of 4-(3-nitrophenyl)morpholine, 234g of sodium dihydrogen phosphate dihydrate, and 3L of acetonitrile into the reaction kettle, heat it to 40°C, and add 169g of 80% chlorous acid dissolved in 650g of water. Sodium is prepared into an aqueous solution and added dropwise to the reaction system. After the dripping is completed, the reaction is continued for about 6 hours, and the reaction is monitored by HPLC. After the reaction is completed, let stand and separate the layers. Collect the organic layer. Add 700 mL of ethyl acetate to the aqueous layer and extract twice. Combine the organic layers and place in a cold water bath. Add about 1 L of saturated sodium sulfite aqueous solution and stir for 10 minutes. Add 500 mL of aqueous layer. Extract twice with ethyl acetate, combine the organic phases again, add anhydrous sodium sulfate to dry, and concentrate under reduced pressure to obtain a yellow solid. Add 240 mL of mixed solvent (petroleum ether: ethyl acetate = 5:1 (V: V)). Stir for 20 minutes and process to obtain 106g of yellow solid, with a yield of 95.9%, an HPLC purity of 95.7%, about 3.1% of raw materials, and a maximum impurity of 1.1%. When reacting for 6 hours, the purity of the reaction solution was 83.8%, the raw material was about 5.11%, and the maximum impurity was 2.6%.

Claims (6)

1. The synthesis method of the lactam compound is characterized in that sodium chlorite is used as an oxidant, and the cyclic amine compound shown in the formula II is oxidized into the lactam compound shown in the formula I under the catalysis of carbon dioxide:
wherein the method comprises the steps of
When n=0 or 1, X is CH 2
When n=2, X is O or CH 2
R is selected from phenyl, benzyl, pyridyl, said phenyl and benzyl optionally being substituted with one or moreA plurality of compounds selected from hydrogen, halogen, nitro, trifluoromethyl, cyano, C 1 -C 6 Alkyl, C 1 -C 6 Acyl, C 1 -C 6 The substituent of the alkoxy group is substituted.
2. The method of claim 1, wherein the molar ratio of cyclic amine compound to oxidizer sodium chlorite is 1:1 to 1:10.
3. the method of claim 2, wherein the molar ratio of cyclic amine compound to oxidizer sodium chlorite is 1: 2-1: 6.
4. the synthesis according to claim 1, wherein the reaction temperature is 0 to 100 ℃.
5. The method according to claim 4, wherein the reaction temperature is 20 to 80 ℃.
6. The method according to claim 1, wherein the solvent is aprotic solvent selected from the group consisting of nitrile solvents, ether solvents, toluene, acetone, and methylene chloride.
CN202210417647.9A 2021-04-16 2022-04-09 A kind of synthesis method of lactam compounds Active CN115215816B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202110438690 2021-04-16
CN2021104386909 2021-04-16

Publications (2)

Publication Number Publication Date
CN115215816A CN115215816A (en) 2022-10-21
CN115215816B true CN115215816B (en) 2024-02-02

Family

ID=83606612

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210417647.9A Active CN115215816B (en) 2021-04-16 2022-04-09 A kind of synthesis method of lactam compounds

Country Status (2)

Country Link
CN (1) CN115215816B (en)
WO (1) WO2022218348A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112939893A (en) * 2019-12-10 2021-06-11 普济生物科技(台州)有限公司 Synthesis method of 4- (4-aminophenyl) -3-morpholinone

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112939893A (en) * 2019-12-10 2021-06-11 普济生物科技(台州)有限公司 Synthesis method of 4- (4-aminophenyl) -3-morpholinone

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Facile Preparation of 4-(4-Nitrophenyl)morpholin-3-one via the Acid-Catalyzed Selective Oxidation of 4-(4-Nitrophenyl)morpholine by Sodium Chlorite as the Sole Oxidant";Chaoyang Liu et al.;《Org. Process Res. Dev.》;第24卷(第11期);第 2633–2638页 *
"Lactamization of sp2 C−H Bonds with CO2: Transition-Metal-Free and Redox-Neutral";Zhen Zhang et al.;《Angewandte Chemie》;第128卷(第25期);第7184-7188页 *

Also Published As

Publication number Publication date
WO2022218348A1 (en) 2022-10-20
CN115215816A (en) 2022-10-21

Similar Documents

Publication Publication Date Title
CN101906068A (en) Preparation method of 2-pyridine carboxaldehyde
Mao et al. Novel Schiff base complexes as catalysts in aerobic selective oxidation of β-isophorone
Azizi et al. Deep eutectic solvent mediated rapid and selective one-pot synthesis of 5-alkylidene-Thiazolones
CN115710199B (en) Photooxidation reduction catalytic process
CN115215816B (en) A kind of synthesis method of lactam compounds
CN110183378A (en) A kind of derivative and its process for catalytic synthesis of niacinamide
CN117051414A (en) A method for electrochemical synthesis of aromatic sulfonyl fluoride compounds
CN109574913B (en) A kind of method for preparing geminal dinitro compound with nitrate hydrate
WO2010122794A1 (en) Process for production of pyrazinecarboxylic acid derivative, and intermediate for the production
CN108059591A (en) A kind of catalysis method of asymmetric synthesis of chiral alpha-fluoro-beta-acetenyl ketone compound
CN108003091B (en) A method of vismodegib is prepared using microchannel reaction unit
CN113264843B (en) Synthetic method of 3-aminobicyclo [1.1.1] pentane-1-carboxylic ester derivative
Zhao et al. Electrosynthesis of methyl 2-ureidobenzoates via a C2–C3 bond cleavage of isatins
CN108863739A (en) A method of cyclohexene derivative is constructed by aryl methyl ketone and 2- aryl propylene and dimethyl sulfoxide
CN115215764B (en) Preparation method of deuterated aromatic nitrile compound
CN113897631B (en) Method for electrochemically synthesizing pyridin-2-one derivatives
JP6067700B2 (en) Alcohol oxidation catalyst and alcohol oxidation method using the same
CN110590636A (en) A kind of 4-sulfonylpyrrolone compound and its synthetic method
CN113024431B (en) A photocatalytic synthesis method of (E)-1,2-diselenocyanoalkene compound
CN117362287A (en) Synthesis method of apixaban
CN111925291B (en) Preparation method of 3, 4-disubstituted alpha-tetralone compound
CN105061125A (en) Synthesis method for 1,5-ketonic ester compound under catalyzing of inorganic base
CN116143688A (en) A kind of preparation method of 3-piperidone compound
CN108484602A (en) A kind of preparation method of polysubstituted aza-tricycle oxazine derivatives
CN113651684A (en) Preparation method of 4-hydroxy-2-butynoic acid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant